How Much Does Trodelvy Cost?
Trodelvy (Sacituzumab Govitecan) costs an average of $15,643 per Medicare Part D claim, with total Medicare spending of $876.0M in the latest year. A generic version is available, which may reduce out-of-pocket costs.
Key Data
| Metric | Value |
|---|---|
| Avg Cost Per Claim | $15,643 |
| Total Medicare Spending | $876.0M |
| Total Claims | 56,000 |
| Beneficiaries | 6,400 |
| Generic Available | Yes |
| Year-Over-Year Change | +68.4% |
Trodelvy (Sacituzumab Govitecan) costs an average of $15,643 per Medicare Part D claim, with total Medicare spending of $876.0M in the latest year. A generic version is available, which may reduce out-of-pocket costs.